Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-21 Tax Withholding | 2026-10-23 4:15 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Cobo Marc Principal Accounting Officer | 203 | $2.68 | 13,812 (Direct) | View |
| 2026-10-01 Tax Withholding | 2026-10-05 4:14 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Cobo Marc Principal Accounting Officer | 126 | $3.94 | 14,015 (Direct) | View |
| 2026-10-01 Tax Withholding | 2026-10-05 4:13 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Elmelech Idan COO & Principal Financial Ofcr | 343 | $3.94 | 14,152 (Direct) | View |
| 2026-10-01 Tax Withholding | 2026-10-05 4:12 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,047 | $3.94 | 43,529 (Direct) | View |
| 2026-10-01 Tax Withholding | 2026-10-05 4:11 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Ben Yong Chief Med & Dev Officer | 1,047 | $3.94 | 43,529 (Direct) | View |
| 2026-09-10 Tax Withholding | 2026-09-14 4:24 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Cobo Marc Principal Accounting Officer | 203 | $5.52 | 57,841 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 4:24 pm | N/A 2036-09-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Cobo Marc Principal Accounting Officer | 52,738 | $0 | 57,841 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-06 6:00 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Cobo Marc Principal Accounting Officer | 125 | $7.8 | 5,306 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-06 6:00 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Elmelech Idan COO & Principal Financial Ofcr | 343 | $7.8 | 14,495 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-06 6:00 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Ben Yong Chief Med & Dev Officer | 1,047 | $7.8 | 44,576 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-06 6:00 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,047 | $7.8 | 44,576 (Direct) | View |
| 2026-07-01 Other | 2026-07-06 4:34 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Chen Bihua Director 10% Owner | 9,056,372 | $0 | 17,044,639 (Indirect) | View |
| 2026-06-16 Option Award | 2026-06-18 4:59 pm | N/A 2036-06-15 | BridgeBio Oncology Therapeutics Inc. | BBOT | Tipirneni Praveen P. Director | 31,675 | $0 | 31,675 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:58 pm | N/A 2036-06-15 | BridgeBio Oncology Therapeutics Inc. | BBOT | MCCORMICK FRANK Director | 31,675 | $0 | 31,675 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:57 pm | N/A 2036-06-15 | BridgeBio Oncology Therapeutics Inc. | BBOT | Lebowitz Peter F Director | 7,289 | $0 | 7,289 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:56 pm | N/A 2036-06-15 | BridgeBio Oncology Therapeutics Inc. | BBOT | Kelleher Raymond J. Director | 31,675 | $0 | 31,675 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:55 pm | N/A 2036-06-15 | BridgeBio Oncology Therapeutics Inc. | BBOT | Chen Bihua Director 10% Owner | 31,675 | $0 | 31,675 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:54 pm | N/A 2036-06-15 | BridgeBio Oncology Therapeutics Inc. | BBOT | Bauer Jake Director | 31,675 | $0 | 31,675 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:53 pm | N/A 2036-06-15 | BridgeBio Oncology Therapeutics Inc. | BBOT | Kumar Neil Director | 31,675 | $0 | 31,675 (Direct) | View |
| 2026-05-10 Option Award | 2026-05-12 4:12 pm | N/A 2036-05-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Elmelech Idan COO & Principal Financial Ofcr | 758,222 | $0 | 758,222 (Direct) | View |
| 2026-05-10 Option Award | 2026-05-12 4:11 pm | N/A 2036-05-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,103,837 | $0 | 1,103,837 (Direct) | View |
| 2026-04-01 Tax Withholding | 2026-05-05 7:05 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Ben Yong Chief Med & Dev Officer | 1,047 | $9.03 | 45,623 (Direct) | View |
| 2026-04-01 Tax Withholding | 2026-05-05 7:03 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,047 | $9.03 | 45,623 (Direct) | View |
| 2026-04-01 Tax Withholding | 2026-05-05 7:01 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Mehra Uneek Former Officer | 524 | $9.03 | 22,806 (Direct) | View |
Ownership | 2026-04-30 4:17 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Cobo Marc Principal Accounting Officer | 0 | $0 | 159,646 (Direct) | View |
Ownership | 2026-04-30 4:16 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Elmelech Idan COO & Principal Financial Ofcr | 0 | $0 | 325,132 (Direct) | View |
| 2026-03-24 Option Award | 2026-03-26 5:14 pm | N/A 2036-03-23 | BridgeBio Oncology Therapeutics Inc. | BBOT | Lebowitz Peter F Director | 63,350 | $0 | 63,350 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:58 pm | N/A 2036-03-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Mehra Uneek Chief Financial Officer | 128,330 | $0 | 128,330 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:57 pm | N/A 2036-03-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro Chief Scientific Officer | 256,670 | $0 | 256,670 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:56 pm | N/A 2036-03-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Ben Yong Chief Med & Dev Officer | 256,670 | $0 | 256,670 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-05 7:22 pm | N/A 2035-12-31 | BridgeBio Oncology Therapeutics Inc. | BBOT | Wallace Eli M. Chief Executive Officer | 1,114,400 | $0 | 1,114,400 (Direct) | View |
| 2025-10-10 Other | 2025-10-16 5:54 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | BridgeBio Pharma LLC BridgeBio Pharma Inc. 10% Owner | 784,720 | $0 | 15,374,566 (Direct) | View |
| 2025-10-02 Option Award | 2025-10-06 4:22 pm | N/A 2035-10-01 | BridgeBio Oncology Therapeutics Inc. | BBOT | Wallace Eli M. Chief Executive Officer | 1,614,400 | $0 | 1,614,400 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-28 4:44 pm | N/A 2035-08-25 | BridgeBio Oncology Therapeutics Inc. | BBOT | Tipirneni Praveen P. Director | 52,269 | $0 | 52,269 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-28 4:43 pm | N/A 2035-08-25 | BridgeBio Oncology Therapeutics Inc. | BBOT | MCCORMICK FRANK Director | 91,076 | $0 | 91,076 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-28 4:41 pm | N/A 2035-08-25 | BridgeBio Oncology Therapeutics Inc. | BBOT | Bauer Jake Director | 138,193 | $0 | 138,193 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-28 4:39 pm | N/A 2035-08-25 | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro Chief Scientific Officer | 357,177 | $0 | 357,177 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-28 4:37 pm | N/A 2035-08-25 | BridgeBio Oncology Therapeutics Inc. | BBOT | Ben Yong Chief Med & Dev Officer | 357,177 | $0 | 357,177 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-28 4:36 pm | N/A 2035-08-25 | BridgeBio Oncology Therapeutics Inc. | BBOT | Wallace Eli M. Chief Executive Officer | 499,731 | $0 | 499,731 (Direct) | View |